New insights into antigen specific immunotherapy for chronic myeloid leukemia

Chronic myeloid leukemia (CML) is a stem cell disease in which BCR/ABL plays an important role as an oncoprotein and a molecular and immunogenic target. Despite the success of targeted therapy using tyrosine kinase inhibitors (TKIs), CML remains largely incurable, most likely due to the treatment re...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yangqiu, Lin, Chen, Schmidt, Christian A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538626/
https://www.ncbi.nlm.nih.gov/pubmed/23241263
http://dx.doi.org/10.1186/1475-2867-12-52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538626/
https://www.ncbi.nlm.nih.gov/pubmed/23241263
http://dx.doi.org/10.1186/1475-2867-12-52

Ejemplares similares